Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;52(8):1422-1423.
doi: 10.1111/apt.16063.

Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19

Affiliations
Comment

Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19

Ralley E Prentice et al. Aliment Pharmacol Ther. 2020 Oct.

Abstract

LINKED CONTENT

This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The renin‐angiotensin system pathway. 5 Am, aminopeptidase; AT1R angiotensin type 1 receptor; AT2R, angiotensin type 2 receptor; AT4R, angiotensin type 4 receptor; NEP, neutral endopeptidase; PPR, (pro)renin receptor; RAS, renin‐angiotensin system

Comment on

References

    1. Taxonera C, Sagastagoitia I, Alba C, et al. 2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52:276‐283. - PMC - PubMed
    1. Neurath MF. Covid‐19 and immunomodulation in IBD. Gut. 2020;69:1335‐1342. - PMC - PubMed
    1. An P, Menguao J, Megyao J, et al. Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVID‐19 infection in Wuhan, China. Lancet. 2020;5:525–527. - PubMed
    1. Brenner EJ, Ungaro R, Colombel JF, Kappelman MD. Secure‐IBD Database Public Data Update. https://covidibd.org. Accessed June 31, 2020.
    1. Garg M, Royce SG, Tikellis C, et al. Imbalance of the renin‐angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut. 2020;69:841‐851. - PubMed

Substances